Jeff Wolf
Vorstandsvorsitzender bei SCORPIUS HOLDINGS, INC.
Vermögen: 670 732 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| John Monahan | M | 77 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | 15 Jahre |
| Steven Shallcross | M | 62 | 9 Jahre | |
| John Prendergast | M | 70 |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | 8 Jahre |
| Edward Smith | M | 48 |
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX.
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | 15 Jahre |
| William Ostrander | M | 56 | 5 Jahre | |
| Jeffrey Kraws | M | 59 | 18 Jahre | |
| George Peoples | M | - |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | - |
| Rahul R. Jasuja | M | - |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | - |
| Paul Tebbey | M | - |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | 3 Jahre |
| David Waldman | M | - | - | |
| T. J. Swope | M | - | - | |
| Manel Cascalló | M | - | 2 Jahre | |
| Omar Jabado | M | - |
Seed-One Ventures LLC
 Seed-One Ventures LLC Investment ManagersFinance Seed-One Ventures (Seed-One) is a venture capital firm founded in 1997 by Jeff Wolf. The firm is headquartered in Durham, North Carolina. | 14 Jahre |
| Michael Kaleko | M | - | 12 Jahre | |
| Vince Wacher | M | - | - | |
| Elizabeth Posillico | M | - |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | 22 Jahre |
| Ramon Alemany | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jeffrey Riley | M | 61 | 7 Jahre | |
| Steven H. Kanzer | M | 59 | 13 Jahre | |
| Lara M. Guzman | F | - | - | |
| Jeff T. Hutchins | M | 65 | 3 Jahre | |
| Ann A. Rosar | F | 72 | 4 Jahre | |
| Melissa Price | M | 49 | 3 Jahre | |
| Robert James Jakobs | M | 69 | - | |
| Charles Ballantyne | M | 64 | 3 Jahre | |
| Louis C. Bock | M | 59 | 3 Jahre | |
| Josiah Hornblower | M | 48 |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | 8 Jahre |
| Josie Taylor | F | - | - | |
| Andrew Bristol | M | - | - | |
| George J. Brewer | M | - | - | |
| Paul M. Belsky | M | 67 | 7 Jahre | |
| Carol R. Reed | M | 71 | 2 Jahre | |
| Jennifer Lynn Harris | M | 58 | - | |
| Joseph A. Sliman | M | 51 | 5 Jahre | |
| Klaus Gottlieb | M | - | - | |
| Vincent I. Perrone | M | - | - | |
| Nelson K. Stacks | M | 53 | - | |
| Julie A. Caudill | F | - | - | |
| Michael Kharitonov | M | 60 | 7 Jahre | |
| Jeff Himawan | M | 59 |
Seed-One Ventures LLC
Seed-One Ventures LLC Investment ManagersFinance Seed-One Ventures (Seed-One) is a venture capital firm founded in 1997 by Jeff Wolf. The firm is headquartered in Durham, North Carolina. | 5 Jahre |
| Scott Tarriff | M | 64 | 8 Jahre | |
| Matthew E. Czajkowski | M | 73 | 2 Jahre | |
| A. Joseph Rudick | M | 67 | 3 Jahre | |
| Timothy J. Creech | M | 63 | 1 Jahre | |
| Charles Bisgaier | M | 71 | 2 Jahre | |
| Kris M. Maly | F | - | - | |
| James Kuo | M | 58 | 5 Jahre | |
| Lyman Max Lyon | M | - | 1 Jahre | |
| Matthew M. Seavey | M | - | - | |
| George Fromm | M | 45 | 3 Jahre | |
| Suresh de Silva | M | 45 | 3 Jahre | |
| Guillermo Arana | M | - | - | |
| Deb Mathews | M | - | - | |
| Raymond Stapleton | M | - | 4 Jahre | |
| Maureen Early | F | - | - | |
| Taylor Schreiber | M | 44 | 2 Jahre | |
| Daniel J. Dorman | M | 61 | 1 Jahre | |
| Vadim V. Deyev | M | 58 | - | |
| Lewis Barrett | M | - | 2 Jahre | |
| Sandra Silberman | M | 69 | - | |
| Nicholas Stergis | M | 50 | 8 Jahre | |
| Janice Marie McCourt | F | - | - | |
| Olivia Coughlin | M | - | - | |
| Heidi Whalen | F | - | - | |
| Isaac Bright | M | - | - | |
| Robert Gundel | M | - | 1 Jahre | |
| Stephen DiPalma | M | 66 | - | |
| Anil K. Goyal | M | 59 | 3 Jahre | |
| Kay Stremler | M | - | - | |
| Frank Tufaro | M | 69 | 1 Jahre | |
| David A. Newsome | M | - | 5 Jahre | |
| Mei Burris | F | - | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 72 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
